Starpharma Holdings Limited (ASX:SPL) has launched VivaGel® BV in Central and Eastern European region. VivaGel® BV is now available Over the counter (OTC) in Western and Eastern European countries.
Moreover, further launches are also intended in other Mundipharma territories, including in Asia, as well as regulatory activities continue in multiple regions.
Post announcement share price of SPL climbed by 7.938% to A$1.047 (at AEST 12:08 PM) on 16 June 2020.